S. Vincent Rajkumar
0000-0002-5862-1833
Publication & Citation Trends
Publications
0 total
P812: PREDICTING HIGH-RISK DISEASE BIOLOGY USING ARTIFICIAL INTELLIGENCE BASED FDG PET/CT RADIOMICS IN NEWLY DIAGNOSED MULTIPLE MYELOMA OA
Cited by 0
Semantic Scholar
P-448 Impact of molecular cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas
Cited by 0
Semantic Scholar
Relationship among three common hematological premalignant conditions OA
Cited by 5
Semantic Scholar
P975: THREE-DIMENSIONAL TELOMERE PROFILING PREDICTS RISK OF RELAPSE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS OA
Cited by 1
Semantic Scholar
P-126 Adding value of serum-free light chain in assessing response and progression in multiple myeloma with measurable disease
Cited by 0
Semantic Scholar
P-281 Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory MM
Cited by 0
Semantic Scholar
P-093 Solitary plasmacytoma: single institution experience and systematic review and meta-analysis of clinical outcomes
Cited by 0
Semantic Scholar
P885: SOLITARY PLASMACYTOMA: SINGLE INSTITUTION EXPERIENCE AND SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL OUTCOMES OA
Cited by 0
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(1307)
Protein Degradation and Inhibitors
(461)
Amyloidosis: Diagnosis, Treatment, Outcomes
(371)
Cancer Treatment and Pharmacology
(269)
Chronic Lymphocytic Leukemia Research
(242)
Affiliations
University of Maryland, Baltimore
Cedars-Sinai Medical Center
Toyota Motor Corporation (Switzerland)
University of Leeds
Cleveland Clinic